GH Research Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Selling, General & Admin	11.4	10.07	6.55	0.11	0.01
Research & Development	29.82	20.48	8.55	0.34	0.3
Operating Expenses	41.22	30.55	15.1	0.45	0.31
Operating Income	-41.22	-30.55	-15.1	-0.45	-0.31
Interest Expense / Income	0.72	0.12	0.01	0	0
Other Expense / Income	-6.36	-8.22	-5.91	-	-
Pretax Income	-35.59	-22.46	-9.2	-0.45	-0.31
Net Income	-35.59	-22.46	-9.2	-0.45	-0.31
Shares Outstanding (Basic)	52	52	52	49	-
Shares Change	-	-	6.48%	-	-
EPS (Basic)	-0.68	-0.43	-0.21	-0.02	-0.01
EPS (Diluted)	-0.68	-0.43	-0.21	-0.02	-0.01
Free Cash Flow	-37.07	-26.74	-15.38	-0.33	-0.29
Free Cash Flow Per Share	-0.71	-0.51	-0.30	-0.01	-
EBITDA	-34.55	-22.29	-9.17	-0.45	-0.31
Depreciation & Amortization	0.32	0.05	0.02	0	0
EBIT	-34.86	-22.33	-9.19	-0.45	-0.31

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).